320 related articles for article (PubMed ID: 33324861)
1. Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents.
Al Khalifah RA; Florez ID; Zoratti MJ; Dennis B; Thabane L; Bassilious E
J Endocr Soc; 2021 Jan; 5(1):bvaa155. PubMed ID: 33324861
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
Al Khalifah RA; Flórez ID; Dennis B; Neupane B; Thabane L; Bassilious E
Syst Rev; 2015 Sep; 4():125. PubMed ID: 26420636
[TBL] [Abstract][Full Text] [Related]
3. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
Al Khalifah RA; Florez ID; Dennis B; Thabane L; Bassilious E
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244814
[TBL] [Abstract][Full Text] [Related]
4. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
[TBL] [Abstract][Full Text] [Related]
6. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
[TBL] [Abstract][Full Text] [Related]
8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
9. Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis.
Luque-Ramírez M; Nattero-Chávez L; Ortiz Flores AE; Escobar-Morreale HF
Hum Reprod Update; 2018 Mar; 24(2):225-241. PubMed ID: 29293982
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS.
Burchall GF; Piva TJ; Ranasinha S; Teede HJ
Thromb Haemost; 2017 Nov; 117(11):2053-2062. PubMed ID: 29202210
[No Abstract] [Full Text] [Related]
11. A randomized, controlled trial comparing the metformin, oral contraceptive pills and their combination in patients with polycystic ovarian syndrome.
Kumar Y; Kotwal N; Singh Y; Upreti V; Somani S; Hari Kumar KVS
J Family Med Prim Care; 2018; 7(3):551-556. PubMed ID: 30112307
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review.
Rajashekar S; Giri Ravindran S; Kakarla M; Ausaja Gambo M; Yousri Salama M; Haidar Ismail N; Tavalla P; Uppal P; Mohammed SA; Hamid P
Cureus; 2022 May; 14(5):e25340. PubMed ID: 35774693
[TBL] [Abstract][Full Text] [Related]
13. Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
Glintborg D; Altinok ML; Mumm H; Hermann AP; Ravn P; Andersen M
J Clin Endocrinol Metab; 2014 Jul; 99(7):2584-91. PubMed ID: 24742124
[TBL] [Abstract][Full Text] [Related]
14. Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Sahu A; Tripathy P; Mohanty J; Nagy A
J Gynecol Obstet Hum Reprod; 2019 May; 48(5):335-339. PubMed ID: 30316907
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY
Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531
[TBL] [Abstract][Full Text] [Related]
16. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
17. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis.
Wang A; Mo T; Li Q; Shen C; Liu M
Endocrine; 2019 May; 64(2):220-232. PubMed ID: 30911997
[TBL] [Abstract][Full Text] [Related]
19. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
